TRUMY (Terumo) Accounts Payable: $566 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRUMY Terumo Corp TRUMY
88 GF Score
Price $15.85
GF Value $19.57
Valuation Modestly Undervalued
View Full Analysis

What is Terumo Accounts Payable?

Terumo TRUMY +9.01% 88 Accounts Payable is $566 Mil as of Mar. 2026. GuruFocus rates TRUMY with a GF Score™ of 88/100 and a GF Value™ of $19.57 (Modestly Undervalued).

Terumo's Accounts Payable for the quarter that ended in Mar. 2026 was $566 Mil.

Terumo's quarterly Accounts Payable declined from Sep. 2025 ($689 Mil) to Dec. 2025 ($625 Mil) and declined from Dec. 2025 ($625 Mil) to Mar. 2026 ($566 Mil).

Terumo's annual Accounts Payable declined from Mar. 2024 ($626 Mil) to Mar. 2025 ($611 Mil) and declined from Mar. 2025 ($611 Mil) to Mar. 2026 ($566 Mil).

Terumo Accounts Payable Historical Data

* Premium members only.

The historical data trend for Terumo's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Accounts Payable Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 687.69 731.21 625.89 610.70 565.63

Terumo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 610.70 589.60 689.43 625.25 565.63
TRUMY
88GF Score
Terumo Corp TRUMY
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Terumo Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $566 Mil mean?
Terumo (TRUMY) has a Accounts Payable of $566 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Terumo and its competitors.
Is Terumo's Accounts Payable too high?
Terumo's current Accounts Payable is $566 Mil. Overall, Terumo has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Accounts Payable compare to ISRG and BDX?
Terumo's Accounts Payable of $566 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Terumo and its competitors. Terumo's current Accounts Payable is $566 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TRUMY) is currently considered Modestly Undervalued. The stock's GF Value™ is $19.57, compared to a current price of $15.85 — trading 19% below its estimated fair value. The current Accounts Payable is $566 Mil. Terumo's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Terumo (TRUMY), the current Accounts Payable is $566 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (TRUMY) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of $15.85 is trading 19% below its estimated GF Value™ of $19.57. GuruFocus considers Terumo to be Modestly Undervalued.

Key valuation signals for TRUMY:

  • Accounts Payable: $566 Mil
  • GF Value™: $19.57 vs. price of $15.85 (19% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the TRUMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
88GF Score

Get the complete analysis for TRUMY

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.85
Price
$19.57
GF Value